1. Home
  2. FWDI vs DRUG Comparison

FWDI vs DRUG Comparison

Compare FWDI & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Forward Industries Inc.

FWDI

Forward Industries Inc.

N/A

Current Price

$7.02

Market Cap

738.4M

Sector

Industrials

ML Signal

N/A

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$85.45

Market Cap

856.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FWDI
DRUG
Founded
1961
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Pharmaceuticals and Biotechnology
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
738.4M
856.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FWDI
DRUG
Price
$7.02
$85.45
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$106.75
AVG Volume (30 Days)
730.1K
270.8K
Earning Date
02-12-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,187,525.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.32
$23.18
52 Week High
$46.00
$123.75

Technical Indicators

Market Signals
Indicator
FWDI
DRUG
Relative Strength Index (RSI) 42.46 50.62
Support Level $7.08 $81.72
Resistance Level $8.00 $91.00
Average True Range (ATR) 0.56 5.61
MACD -0.06 -0.90
Stochastic Oscillator 1.06 27.71

Price Performance

Historical Comparison
FWDI
DRUG

About FWDI Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as tablets, personal computers, barcode Scanners, GPS devices, and others. The company operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment, provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the Design segment.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: